- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Venmax Drugs and Pharmaceuticals Ltd — Board Meeting, 07-08-2026: Board Meeting
07-08-2026 | 04:56 pm
07-08-2026 | 04:56 pm
Venmax Drugs Board just approved Q1 FY27 results: Revenue ₹2.48 Cr, Profit ₹0.12 Cr. Also, 7.8 lakh share warrants were forfeited due to non-payment, boosting company funds by ₹0.39 Cr.
No comments yet. Be the first to comment!